Jang, S.-I.; Cho, J.-H.; Kim, S.-Y.; Hong, I.-Y.; Park, J.-S.; Lee, H.-S.; Park, G.; Kim, J.-K.; Lee, H.-K.; Lee, D.-K.
Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. Cancers 2022, 14, 853.
https://doi.org/10.3390/cancers14030853
AMA Style
Jang S-I, Cho J-H, Kim S-Y, Hong I-Y, Park J-S, Lee H-S, Park G, Kim J-K, Lee H-K, Lee D-K.
Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. Cancers. 2022; 14(3):853.
https://doi.org/10.3390/cancers14030853
Chicago/Turabian Style
Jang, Sung-Ill, Jae-Hee Cho, So-Young Kim, In-Young Hong, Joon-Seong Park, Hye-Sun Lee, Goeun Park, Jong-Kyoung Kim, Hyung-Keun Lee, and Dong-Ki Lee.
2022. "Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma" Cancers 14, no. 3: 853.
https://doi.org/10.3390/cancers14030853
APA Style
Jang, S. -I., Cho, J. -H., Kim, S. -Y., Hong, I. -Y., Park, J. -S., Lee, H. -S., Park, G., Kim, J. -K., Lee, H. -K., & Lee, D. -K.
(2022). Validation of IL-7R as an Immunological Biomarker for Human Pancreatic Ductal Adenocarcinoma. Cancers, 14(3), 853.
https://doi.org/10.3390/cancers14030853